Significant Unmet Medical Needs Accelerating the Growth of the Global Acne Drugs Market, Says Technavio

LONDON--()--According to the latest research study released by Technavio, the global acne drugs market is expected to reach close to USD reach USD 4.4 billion by 2020.

This research report titled ‘Global Acne Drugs Market 2016-2020’, provides an in-depth analysis of market growth in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all leading regions.

Request sample report: http://bit.ly/1puki6g

“Many acne drugs are available in the market. However, these drugs provide symptomatic treatment and do not cure the condition. Symptomatic treatment involves the reduction of acne lesions by almost 50% and not the suppression of acne recurrence. Most people with acne use isotretinoin to relieve their condition. However, this drug has teratogenic effects and cannot be prescribed for pregnant women. Development of drugs with a novel mechanism of action to target acne, with high efficacy and safety profiles, is therefore the need of the hour,” said Barath Palada, one of Technavio’s lead analysts for life science research.

“The market presents significant growth opportunities for vendors due to the rising prevalence of acne. Many companies are investing in drug discovery and R&D of acne drugs. Many drug candidates, currently in their late developmental stages, will likely be launched in the market during the forecast period,” added Barath.

Glance at the global acne drugs market segmentation by drug class

  • Antibiotics
  • Anti-inflammatory drugs
  • Antimicrobials
  • Combination drugs
  • Hormonal agents
  • Oral retinoids
  • Topical retinoids

Source: Technavio research

Antibiotics

Antibiotics are used to inhibit bacterial growth. In acne treatment, antibiotics reduce bacterial growth surrounding the follicle and associated inflammatory response. They are available in the form of topical preparations for treating mild acne and as tablets, capsules, and elixirs for oral use in treating moderate and severe acne. Clindamycin or erythromycin is the most commonly prescribed topical antibiotic. Minocycline, doxycycline, and trimethoprim alone or in combination with sulfamethoxazole and azithromycin are commonly prescribed antibiotics for systemic use.

Anti-inflammatory drugs

Acne is a common inflammatory condition of the skin's sebaceous glands, causing pimples, whiteheads, blackheads, skin bumps, and skin redness. Anti-inflammatory drugs provide relief by reducing skin inflammation. Benzoyl peroxide, tetracycline, and derivatives of doxycycline are some of the anti-inflammatory drugs used to treat acne.

Antimicrobials

Antimicrobials kill microorganisms or restrict their growth. These drugs can be categorized based on the type of microorganisms they are used against. In the treatment of acne, antimicrobials are administered in combination with topical retinoids for clearing lesions and reducing treatment duration. Benzoyl peroxide is a major antimicrobial used to treat acne.

Combination drugs

Combination drugs consist of two or more acne-preventing ingredients. Using different acne treatment ingredients together can enhance the effectiveness of each ingredient. Duac (clindamycin 1% and benzoyl peroxide 5%) and Ziana (clindamycin 1.2% and tretinoin 0.025%) are some combination drugs used to treat acne.

Hormonal agents

Hormonal agents can effectively treat severe acne in women with hormonal imbalance. Diane-35, a combination of estrogen and progestin is one such hormonal agent used for the treatment of severe acne.

Oral retinoids

Oral retinoids act through the vitamin A pathway. These drugs help prevent excessive oil production, bacterial acne growth, and inflammation. Oral retinoids are used to treat severe cases of acne. They are also used in cases when other treatments result in continuous relapse. Isotretinoin capsules are a major oral retinoid used to treat acne.

Topical retinoids

Topical retinoids are formulated using the derivatives of vitamin A. When applied to the skin, topical retinoids can unblock pores and permit other topical medications to enter infected areas. These drugs help increase cell turnover and reduce acne breakouts. Tretinoin and adapalene are some of the topical retinoids used to treat acne.

Browse related reports:

Purchase any three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact enquiry@technavio.com with your requirements and a link to our subscription platform.

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
media@technavio.com

Release Summary

According to the latest research study released by Technavio, the global acne drugs market is expected to reach close to USD reach USD 4.4 billion by 2020.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com
media@technavio.com